February 02, 2013

Recurring corneal melts in patients with rheumatoid disease may respond best to aggressive therapy which can include biologic modalities such as infliximab, an inhibitor of tumour necrosis factor-alpha (TNFα), according to a case study presented by Dipak Parmar FRCOphth, FRANZCO, London, UK, at the Cornea Day session at the 16th EsCRs Winter Meeting

Hyperopic Lasik

February 02, 2013

The use of improved aspheric ablation profiles and larger optical zones means that LAsiK can now be proposed as a safe and predictable method to correct hyperopia in patients with or without astigmatism up to 6.0 D, reports Diego de Ortueta MD, FEBO.

Optimised Femtosecond Laser System

February 02, 2013

The Catalys™ Precision Laser system (OptiMedica), a next generation femtosecond laser system optimised for cataract surgery, performs anterior capsulotomies with greater precision than that achieved manually by experienced surgeons and all but eliminates the need for ultrasound during lens emulsification and removal, said h Burkhard Dick MD, PhD, Ruhr University Eye Clinic, Bochum, Germany.

Phakic IOL

February 02, 2013

Phakic iOL candidates require a comprehensive workup to rule out any potential anatomic or physiological problems, Jan Venter MD, London, told delegates attending the XXXV UKisCRs Congress.

Combined Phacoemulsification And Trabulectomy Surgeries

February 02, 2013

Combined phacoemulsification and trabeculectomy surgeries tend to amount to less than the sum of their parts in terms of intraocular pressure reduction.

Latest Events